Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Operating Leases (2019 - 2025)

Amphastar Pharmaceuticals has reported Operating Leases over the past 7 years, most recently at $45.6 million for Q4 2025.

  • Quarterly results put Operating Leases at $45.6 million for Q4 2025, up 8.91% from a year ago — trailing twelve months through Dec 2025 was $45.6 million (up 8.91% YoY), and the annual figure for FY2025 was $45.6 million, up 8.91%.
  • Operating Leases for Q4 2025 was $45.6 million at Amphastar Pharmaceuticals, up from $39.4 million in the prior quarter.
  • Over the last five years, Operating Leases for AMPH hit a ceiling of $45.6 million in Q4 2025 and a floor of $16.5 million in Q1 2021.
  • Median Operating Leases over the past 5 years was $27.1 million (2022), compared with a mean of $29.6 million.
  • Biggest five-year swings in Operating Leases: surged 54.82% in 2022 and later dropped 5.87% in 2023.
  • Amphastar Pharmaceuticals' Operating Leases stood at $24.7 million in 2021, then dropped by 4.08% to $23.7 million in 2022, then rose by 25.44% to $29.7 million in 2023, then surged by 40.91% to $41.9 million in 2024, then grew by 8.91% to $45.6 million in 2025.
  • The last three reported values for Operating Leases were $45.6 million (Q4 2025), $39.4 million (Q3 2025), and $39.0 million (Q2 2025) per Business Quant data.